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When the body gets infected by a pathogen or receives a vaccine dose, the immune
system develops pathogen-specific immunity. Induced immunity decays in time and
years after recovery/vaccination the host might become susceptible again. Expo-
sure to the pathogen in the environment boosts the immune system thus prolonging
the duration of the protection. Such an interplay of within host and population
level dynamics poses significant challenges in rigorous mathematical modeling of
immuno-epidemiology. The aim of this paper is twofold. First, we provide an
overview of existing models for waning of disease/vaccine-induced immunity and
immune system boosting. Then a new modeling approach is proposed for SIRVS
dynamics, monitoring the immune status of individuals and including both waning
immunity and immune system boosting. We show that some previous models can
be considered as special cases or approximations of our framework.
1. Introduction
Models of SIRS type are a traditional topic in mathematical epidemiology.
Classical approaches present a population divided into susceptibles (S), in-
fectives (I) and recovered (R), and consider interactions and transitions
among these compartments9. Susceptibles are those hosts who either did
not contract the disease in the past or lost immunity against the disease-
causing pathogen. When a susceptible host gets in contact with an infective
one, the pathogen can be transmitted from the infective to the suscepti-
ble and with a certain probability the susceptible host becomes infective
himself. After pathogen clearance the infective host recovers and becomes
immune for some time, afterward he possibly becomes susceptible again (in
certain cases one can talk of life-long immunity). The model can be ex-
tended by adding vaccination. Vaccinees (V) are protected from infection
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for some time, usually shorter than naturally infected hosts.
From the in-host point of view, immunity to a pathogen is the result of
either active or passive immunization. The latter is a transient protec-
tion due to the transmission of antibodies from the mother to the fetus
through the placenta. The newborn is thus immune for several months af-
ter birth26. Active immunization is either induced by natural infection or
can be achieved by vaccine administration35,15.
Let us first consider the case of natural infection. A susceptible host,
also called naive host, has a very low level of specific immune cells for a
pathogen (mostly a virus or a bacterium). The first response to a pathogen
is nonspecific, as the innate immune system cannot recognize the physi-
cal structure of the pathogen. The innate immune response slows down
the initial growth of the pathogen, while the adaptive (pathogen-specific)
immune response is activated. Clonal expansion of specific immune cells
(mostly antibodies or CTL cells) and pathogen clearance follow. The pop-
ulation of pathogen-specific immune cells is maintained for long time at
a level that is much higher than in a naive host. These are the so-called
memory cells and are activated in case of secondary infection (see Figure
1, adapted from Barbarossa and Ro¨st6). Memory cells rapidly activate the
immune response and the host mostly shows mild or no symptoms2.
Each exposure to the pathogen might have a boosting effect on the pop-
ulation of specific memory cells. Indeed, the immune system reacts to a
new exposure as it did during primary infection, thus yielding an increased
level of memory cells. Though persisting for long time after pathogen clear-
ance, the memory cell population slowly decays and in the long run the host
might lose his pathogen-specific immunity37.
Vaccine-induced immunity works in a similar way as immunity induced
by the natural infection. Agents contained in vaccines resemble, in a weaker
form, the disease-causing pathogen and force a specific immune reaction
without leading to the disease. If the vaccine is successful, the host is
immunized for some time. Vaccinees experience immune system boosting
and waning immunity, just as hosts recovered from natural infection do. In
general, however, disease-induced immunity induces a much longer lasting
protection than vaccine-induced immunity does35.
Waning immunity might be one of the factors which cause, also in
highly developed regions, recurrent outbreaks of infectious diseases such
as measles, chickenpox and pertussis. On the other side, immune system
boosting due to contact with infectives prolongs the protection duration. In
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Figure 1. Level of pathogen-specific immune cells with respect to the time. The solid
line represents the case of natural infection, the dotted line represents the immune status
of a vaccinated host. Generation of memory cells takes a few weeks: once primary
infection (respectively, vaccination) occurred, the adaptive immune system produces a
high number of specific immune cells (clonal expansion). After pathogen clearance,
specific immune cells (memory cells) are maintained for years at a level that is much
higher than in a naive host. Memory cells are activated in case of secondary infection.
a highly vaccinated population there are a lot of individuals with vaccine-
induced immunity and few infection cases, as well as many individuals with
low level of immunity. In other words, if a high portion of the population
gets the vaccine, there are very few chances for exposure to the pathogen
and consequently for immune system boosting in protected individuals.
In order to understand the role played by waning immunity and immune
system boosting in epidemic outbreaks, in the recent past several math-
ematical models were proposed. Few of these models describe only in-
host processes during and after the infection37,16. Many more models, for-
mulated in terms of ordinary differential equations (ODEs), consider the
problem only at population level, defining compartments for individuals
with different levels of immunity and introducing transitions between these
compartments10,17. Vaccinated hosts or newborns with passive immunity
are often included in the model equations and waning of vaccine-induced
or passive immunity are observed33,31,11,3,22,5,30.
To describe the sole waning immunity process, authors have sometimes
chosen delay differential equation (DDE) models with constant or dis-
tributed delays21,36,8,7,38. The delay represents the average duration of the
disease-induced immunity. However, neither a constant nor a distributed
 
B
IO
M
A
T 
20
14
 D
ow
nl
oa
de
d 
fro
m
 w
w
w
.w
or
ld
sc
ie
nt
ifi
c.
co
m
by
 L
A
 T
RO
BE
 U
N
IV
ER
SI
TY
 o
n 
03
/1
4/
16
. F
or
 p
er
so
na
l u
se
 o
nl
y.
April 29, 2015 13:54 BIOMAT-14-Intl.Symposium mvb˙gr˙biomath2014chap˙FINAL page 188
188
delay allows for the description of immune system boosting.
Models which include partial differential equations (PDEs) mostly de-
scribe an age-structured population27,20,33 and consider pathogen trans-
mission among the different age groups (newborns, children, pupils, adults,
. . . ). Rare examples suggest a physiologically structured approach with
populations structured by the level of immunity, coupling within-host and
between-hosts dynamics25,6.
The goal of the present book chapter is twofold. On the one side, we
found necessary to provide a comprehensive overview of previously pub-
lished models for waning of disease/vaccine-induced immunity and immune
system boosting (Sect. 2). On the other side, in Sect. 3 we propose a new
modeling framework for SIRVS dynamics, monitoring the immune status
of individuals and including both waning immunity and immune system
boosting.
2. Mathematical Models for Waning Immunity and
Immune System Boosting
In the following we provide an overview on previous mathematical models
for waning immunity and immune system boosting. We shall classify these
models according to their mathematical structure (systems of ODEs, PDEs
or DDEs).
2.1. Systems of ODEs
Mossong and coauthors were among the first to suggest the inclusion of
individuals with waning immunity in classical SIRS systems31. Motivated
by the observation that measles epidemics can occur even in highly vac-
cinated populations, the authors set up a model to study the waning of
vaccine-induced immunity and failure of seroconversion as possible causes
for recurrent outbreaks. Their compartmental model includes hosts with
the so-called “vaccine-modified measles infection” (VMMI) which can occur
in people with some degree of passive immunity to the virus, including those
previously vaccinated. Assuming that not all vaccinees are protected from
developing VMMI, the authors classify vaccinees into three groups: imme-
diately susceptible to VMMI (weak response), temporarily protected who
become susceptible to VMMI due to waning of vaccine-induced immunity
(intermediate response), and permanently protected from VMMI (strong
response). Infection occurs due to contact with infectious individuals (both
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regular measles infection and VMMI). The resulting compartmental model
includes waning of vaccine-induced immunity but not of disease-induced
immunity, nor immune system boosting. Similar to McLean and Blower28,
Mossong et al. define a parameter φ to describe the impact of the vaccine:
if φ < 1, then vaccine failure is possible. Analytical results by Mossong and
coauthors31 show that the main effect of VMMI is to increase the overall
reproduction number of the infection.
Inspired by Mossong’s work, in 2003-2004 Glass, Grenfell and
coauthors14,13,12 proposed modifications and extensions of the system by
Mossong et al.31. The basic model is similar to the ODE system by Mossong
et al.31, with a group of subclinical cases which carry the pathogen with-
out showing symptoms11. In addition, the distribution of antibody levels
in immune hosts (included in the ODEs coefficients) and immune system
boosting are introduced: the average antibody level in an immune host in-
creases due to contact with infective or subclinical hosts. This model was
used to fit measles data in England12. Further, Grenfell and coauthors ex-
tend the basic model to consider measles transmission in a meta-population
with N patches13.
Immune system boosting in vaccinees was further studied by Arinamin-
pathy et al.3. The authors introduce two models. In the first one vaccinees
are separated from non-vaccinated hosts. Both groups of individuals are
classified into susceptible, infective and immune, but in contrast to the
models by Glass, Grenfell, Mossong et al.14,13,12,31, there is no compart-
ment for subclinical cases. Non-vaccinated hosts do not undergo immune
system boosting. For vaccinated hosts the authors include a so called “self-
boosting” of vaccine, so that contact with infectives moves susceptible vac-
cinees to the immune vaccinated compartment. The second model extends
the first one with a new compartment for hosts with waning immunity (W).
These can receive immune system boosting due to contact with infectives or
move back to the susceptible compartment due to immunity loss. Numer-
ical simulations show possible sustained oscillations. The SIRWS system
was partially analyzed by Dafilis et al.10.
Heffernan and Keeling16 proposed an in-host model to understand the be-
havior of the immune system during and after an infection. Activation of
immune system effectors and production of memory cells depend on the
virus load. When not stimulated by the virus, the number of activated
cells decays (waning immunity). Vaccination is simulated by changing the
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initial conditions for the virus load. Numerical simulations show that the
number of infected immune system cells in a vaccinated patient reaches
approximately half of what is reached in a patient who undergoes natural
infection. In turn, the level of immunity gained after one dose of vaccine
is the same as the level observed in a measles patient 4 years after natural
infection. The in-host model by Heffernan and Keeling16 was extended by
the same authors to a population model (SEIRS) with waning immunity
and immune system boosting17. In contrast to classical SEIRS models, the
class R refers here to individuals protected by short-term immune memory,
while the class S refers to those individuals who have lost this short-term
protection and may experience immune system boosting. Each compart-
ment is classified according to the level of immunity, which can be related
to the number of memory cells. Newborns are recruited into the susceptible
class S0 (lowest level of immunity). During exposure and infection the host
does not change his level of immunity, that is, transition occurs from Sj to
Ej to Ij for each j ∈ N. Hosts in S and R experience waning immunity
and transit from Sj to Sj−1 (respectively from Rj to Rj−1). Immune sys-
tem boosting is due to recovery from infection and is incorporated into the
equations with transition terms from Ij to Rk, with k ≥ j. The resulting
large system of ODEs, with a very high number of parameters, is quite hard
to approach from an analytical point of view, hence the authors make use
of numerical simulations to investigate the long term behavior. A somehow
simplified version of the ODE system by Heffernan and Keeling17 was pro-
posed by Reluga et al.32. A similar large system of ODEs was introduced
by Lavine et al.22, extending the SIRWS model by Mossong, Glass and
Grenfell31,11, by including several levels of immunity for immune hosts (R)
and hosts with waning immunity (W), as well as age classes for all com-
partments. The authors claim that the model can explain several observed
features of pertussis in US, in particular a shift in the age-specific incidence
and the re-emergence of the disease in a highly vaccinated population.
2.2. System of DDEs
Delay models with constant or distributed delay have been introduced to
describe waning of disease-induced or vaccine-induced immunity. A simple
SIRS system with constant delay is given by
S˙(t) = µ(1 − S(t))− φS(t)f(I(t)) + γI(t− τ)e−µτ
I˙(t) = φS(t)f(I(t)) − (µ+ γ)I(t)
R˙(t) = γI(t)− µR(t)− γI(t− τ)e−µτ .
(1)
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This model was studied by Kyrychko and Blyuss21, who provided results on
existence, uniqueness and non-negativity of solutions, linear and global sta-
bility of the disease-free equilibrium, as well as global stability of the unique
endemic equilibrium. A special case of (1) was considered some years later
by Taylor and Carr36. An extension of system (1) with distributed delay
was proposed by Kyrychko and Blyuss8 and shortly after by Bhattacharya
and Adler7.
A more general model with distributed delay and vaccination was pro-
posed by Arino et al.4. Their system includes three compartments (suscep-
tible, infective and vaccinated hosts) in a population which remains con-
stant in time. Vaccine-induced immunity might be only partial, resulting
in vaccinated individuals becoming infective. Systems of ODEs or DDEs
can be obtained from the general model by a proper choice of the kernel
(see also Hethcote et al.19,18).
Recently, Yuan and Be´lair proposed a SEIRS model with integro-
differential equations which resembles the systems by Arino, Hethcote
et al.4,19. The probability that an individual stays in the exposed class
(E) for t units of time is P (t), hence,
E(t) =
∫ t
0
β
S(u)I(u)
N
e−b(t−u)P (t− u) du.
Similarly, Q(t) is the probability that an individual is immune t units of
time after recovery, thus
R(t) =
∫ t
0
γI(u)e−b(t−u)Q(t− u) du.
For a certain choice of the probabilities P and Q, the problem can be re-
duced to a system with one or two constant delays. The authors show
existence of an endemic equilibrium and boundedness of solutions in a pos-
itive simplex. For the system with one constant delay, results for existence
of a global attractor as well as the proof of persistence of the disease in case
R0 > 1 are provided.
2.3. Systems of PDEs
Structured populations in the context of waning immunity and immune sys-
tem boosting have been motivated in different ways. Often the structure
can be found in the biological age27,26,20,33, and is used to observe disease
transmission among babies, children, adults and seniors. Only few works
suggest models for physiologically structured populations25,6.
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McLean and Anderson27,26 proposed a model for measles transmission
which includes a compartment for babies protected by maternal antibod-
ies. Indeed, mothers who have had measles or have been vaccinated transfer
measles immunity to the baby through the placenta. For several months
after birth (ca. 2 months if the mother was vaccinated, ca. 4 months if she
had the disease26) the baby is still protected by maternal antibodies and
should not be vaccinated. The model by McLean and Anderson27 consid-
ers only waning of maternally induced immunity in the context of measles
infection. Few years before McLean, Katzmann and Dietz20 proposed a bit
more general model, which includes also waning of vaccine-induced immu-
nity. In both cases, the age structure was used to determine the optimal
age for vaccination. A compartment for adult hosts with waning immunity
who can also receive immune system boosting was introduced only years
later by Rouderfer et al.33. A further deterministic system of ODEs for ma-
ternally induced immunity in measles was proposed by Moghadas et al.29.
Different is the approach when physiologically structured populations are
considered. Martcheva and Pilyugin25 suggest an SIRS model in which
infective and recovered hosts are structured by their immune status. In
infective hosts the immune status increases over the course of infection,
while in recovered hosts the immune status decays at some non-constant
rate. When the immune status has reached a critical level, recovered hosts
transit from the immune to the susceptible compartment.
A general framework for SIRS systems, modeling waning immunity and
immune system boosting, and combining the in-host perspective with the
population dynamics, was proposed by Barbarossa and Ro¨st6.
3. A General Modeling Framework
In this section we extend the model by Barbarossa and Ro¨st6 to include
vaccine-induced immunity. As in the works by Martcheva and Pilyugin,
Barbarossa and Ro¨st25,6, we couple the in-host with the between-hosts dy-
namics, focusing on the effects of waning immunity and immune system
boosting on the population dynamics. In contrast to the models proposed
by Heffernan and Keeling, Lavine et al.17,22, we shall maintain the num-
ber of equations as low as possible. The resulting model (V1) is a system
of ODEs coupled with two PDEs. The ODE systems by Mossong, Arino,
Glass, Grenfell et al.31,11,3,5,30, as well as extensions of the DDEs systems
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in the works of Talyor and Carr, Yuan and Be´lair 36,38, can be recovered
from our modeling framework.
Setting up our model we do not restrict ourselves to a particular pathogen.
The model (V1) can be adapted to several epidemic outbreaks (e.g. measles,
chickenpox, rubella, pertussis) by ad-hoc estimating coefficients from avail-
able experimental data24,1,23.
3.1. Model ingredients
3.1.1. Originally susceptible and infectives hosts
Let S(t) denote the total population of originally susceptible hosts. These
are susceptible individuals which have neither received vaccination nor have
been infected before. Newborns enter the susceptible population at rate
b(N), dependent on the total population size N . For simplicity we assume
that the natural death rate d > 0 does not depend on N . Assume that
b : [0,∞) → [0, b+], N 7→ b(N), with 0 < b+ < ∞, is a nonnegative
function, with b(0) = 0. Finally, assume that in absence of disease-induced
death there exists an equilibrium N∗ such that b(N∗) = dN∗.
Let I(t) denote the total infective population at time t. Infection of
susceptible individuals occurs by contact, at rate βI/N . Infected hosts
recover at rate γ > 0. When we include disease-induced death at rate
dI > 0, the equilibrium N
∗ satisfies
b(N∗) = dN∗ + dII
∗.
3.1.2. Immune individuals
Let us denote by r(t, z) the density of recovered individuals with disease-
induced immunity level z ∈ [zmin, zmax] at time t. The total population of
recovered hosts is given by
R(t) =
∫ zmax
zmin
r(t, z) dz.
The parameter z describes the immune status and can be related to the
number of specific immune cells of the host. The value zmax corresponds
to maximal immunity, whereas zmin corresponds to low level of immunity.
Individuals who recover at time t enter the immune compartment with
maximal level of immunity zmax. The level of immunity tends to decay in
time and when it reaches the minimal value zmin, the host becomes sus-
ceptible again. However, exposure to the pathogen can boost the immune
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system from z ∈ [zmin, zmax] to any higher status. It is not straightfor-
ward to determine how this kind of immune system boosting works, as no
experimental data are available. Nevertheless, laboratory analysis on vac-
cines tested on animals or humans suggest that the boosting efficacy might
depend on several factors, among which the current immune status of the
recovered host and the amount of pathogen he receives1,24. Possibly, ex-
posure to the pathogen can restore the maximal level of immunity, just as
natural infection does6.
Let p(z, z˜), z ≥ z˜, z, z˜ ∈ R denote the probability that an individual
with immunity level z˜ moves to immunity level z, when exposed to the
pathogen. Due to the definition of p(z, z˜), we have p(z, z˜) ∈ [0, 1], z ≥ z˜
and
p(z, z˜) = 0, for all z < z˜.
As we effectively consider only immunity levels in the interval [zmin, zmax],
we set
p(z, z˜) = 0, for all z˜ ∈ (−∞, zmin) ∪ (zmax,∞).
Then we have∫ ∞
−∞
p(z, z˜) dz =
∫ zmax
z˜
p(z, z˜) dz = 1, for all z˜ ∈ [zmin, zmax].
Exposure to the pathogen might restore exactly the immunity level induced
by the disease (zmax). In order to capture this particular aspect of immune
system boosting, we write the probability p(z, z˜) as the combination of a
continuous (p0) and atomic measures (Dirac delta):
p(z, z˜) = cmax(z˜)δ(zmax − z˜) + c0(z˜)p0(z, z˜) + c1(z˜)δ(z − z˜),
where
• cmax : [zmin, zmax] → [0, 1], y 7→ cmax(y), is a continuously differ-
entiable function and describes the probability that, due to contact
with infectives, a host with immunity level y boosts to the maximal
level of immunity zmax.
• c0 : [zmin, zmax]→ [0, 1], y 7→ c0(y), is a continuously differentiable
function and describes the probability that, due to contact with
infectives, a host with immunity level y boosts to any other level
z ∈ (y, zmax), according to the continuous probability p0(z, y).
• c1(y) = 1 − cmax(y) − c0(y) describes the probability that get-
ting in contact with infectives, the host with immunity level
y ∈ [zmin, zmax] does not experience immune system boosting.
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The immunity level decays in time at some rate g(z) which is the same
for all recovered individuals with immunity level z. In other words, the
immunity level z follows
d
dt
z(t) = g(z),
with g : [zmin, zmax] → (0,Kg], Kg < ∞ continuously differentiable. The
positivity of g(z) is required from the biological motivation. Indeed, if
g(z˜) = 0 for some value z˜ ∈ [zmin, zmax], there would be no change of
the immunity level at z˜, contradicting the hypothesis of natural decay of
immune status. In absence of immune system boosting, we have that
∫ zmax
zmin
1
g(x)
dx
is the time a recovered host remains immune (see Barbarossa and Ro¨st6).
3.1.3. Vaccination
We structure the vaccinated population by the level of immunity as well.
Let v(t, z) be the density of vaccinees with immunity level z ∈ [zmin, zmax]
at time t. The total population of vaccinated hosts is given by
V (t) =
∫ zmax
zmin
v(t, z) dz.
Vaccination infers a level of immunity zvax, which is lower than the level of
immunity after natural infection: zmax > zvax > zmin
35. As in recovered
individuals, the level of immunity of a vaccinated host tends to decay in
time and when it reaches the minimal value zmin, the host becomes suscep-
tible again. However, also in vaccinated hosts, exposure to the pathogen can
boost the immunity level z ∈ [zmin, zvax] to any higher value in [zmin, zmax].
Immune system boosting is described by the probability p(z, z˜), as in re-
covered hosts. We consider the possibility that exposure to the pathogen
boosts the immune system of a vaccinated individual to z ∈ (zvax, zmax].
Vaccinated hosts with z ∈ (zvax, zmax] have an immune status which can
be compared to the one of hosts who recovered from natural infection.
It is reasonable to assume that in vaccinated individuals the immunity
level decays in time at the same rate g, as in hosts who underwent nat-
ural infection. In absence of exposure to the pathogen (hence in absence
of immune system boosting), the time that a vaccinee remains immune is
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shorter than the time a recovered host does:∫ zvax
zmin
1
g(x)
dx <
∫ zmax
zmin
1
g(x)
dx.
Let us define the vaccination rate at birth α > 0. We assume that originally
susceptible (adult) individuals get vaccinated at rate φ ≥ 0.
3.1.4. Becoming susceptible again
In absence of immune system boosting both disease-induced and vaccine-
induced immunity fade away. Individuals who lose immunity either after
recovery from infection or after vaccination, enter the class S2 of susceptible
individuals who shall not get a new dose of vaccine. A host who had the
disease or got vaccination relies indeed on the induced-immunity and is not
aware of the fact that his level of immunity might have dropped below the
critical immunity threshold.
We denote by S2(t) the population at time t of susceptible hosts who are
not going to receive vaccination.
3.2. Model equations
In view of all what we have mentioned above, we can easily write down
the equations for the compartments S, I and S2. Let initial values S(0) =
S0 ≥ 0, I(0) = I0 ≥ 0 and S2(0) = S02 ≥ 0 be given. The population of
originally susceptible individuals is governed by
S˙(t) = b(N(t))(1 − α)︸ ︷︷ ︸
birth
− φS(t)︸ ︷︷ ︸
vaccination
− βS(t)I(t)
N(t)︸ ︷︷ ︸
infection
− dS(t)︸ ︷︷ ︸
death
, (2)
whereas hosts who become susceptible due to immunity loss follow
S˙2(t) = − βS2(t)I(t)
N(t)︸ ︷︷ ︸
infection
− dS2(t)︸ ︷︷ ︸
death
+ ΛR︸︷︷︸
immunity loss
after recovery
+ ΛV︸︷︷︸
immunity loss
after vaccination
.
The term ΛR (respectively ΛV ), which represents transitions from the im-
mune (respectively, the vaccinated) compartment to the susceptible one,
will be specified below together with the dynamics of the recovered (re-
spectively, vaccinated) population.
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Both kinds of susceptible hosts can become infective due to contact with
infective hosts:
I˙(t) = β
S(t)I(t)
N(t)︸ ︷︷ ︸
infection of S
+ β
S2(t)I(t)
N(t)︸ ︷︷ ︸
infection of S2
− γI(t)︸ ︷︷ ︸
recovery
− dI(t)︸ ︷︷ ︸
natural
death
− dII(t)︸ ︷︷ ︸
disease-induced
death
.
(3)
To obtain an equation for the recovered individuals, structured by their
levels of immunity, one can proceed similarly to size structured models or
as it was done for the immune population by Barbarossa and Ro¨st6. The
result is the following PDE. Let a nonnegative initial distribution r(0, z) =
ψ(z), z ∈ [zmin, zmax] be given. For t > 0, z ∈ [zmin, zmax] we have
∂
∂t
r(t, z)− ∂
∂z
(g(z)r(t, z)) = −dr(t, z) + β I(t)
N(t)
∫ z
zmin
p(z, x)r(t, x) dx
− r(t, z)β I(t)
N(t)
,
(4)
with the boundary condition
g(zmax)r(t, zmax) = γI(t) + β
I(t)
N(t)
∫ zmax
zmin
p(zmax, x)r(t, x) dx. (5)
Equation (4) expresses the rate of change in the density of recovered indi-
viduals according to immune level due to natural waning, mortality, and
boosting. The boundary condition (5) includes newly recovered individu-
als as well as those recovered individuals, who just received a boost which
elevated their immune system to maximal level.
Next we shall consider the vaccinated population. Again, by structuring
this group according to immunity level, one has the PDE
∂
∂t
v(t, z) =
∂
∂z
(g(z)v(t, z))− dv(t, z) + β I(t)
N(t)
∫ z
zmin
p(z, x)v(t, x) dx
− v(t, z)β I(t)
N(t)
+ δ(z − zvax) (φS(t) + αb(N(t))) ,
(6)
and
g(zmax)v(t, zmax) = β
I(t)
N(t)
∫ zmax
zmin
p(zmax, x)v(t, x) dx, (7)
provided with a nonnegative initial distribution v(0, z) = ψv(z), z ∈
[zmin, zmax]. Observe that newly vaccinated hosts do not enter the vac-
cinated population at zmax, but at the lower value zvax, which is expressed
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in equation (6) as an impulse at z = zvax by the term with the Dirac delta
δ(z − zvax).
It becomes evident that the quantity ΛR, initially introduced in the S2
equation to represent the number of hosts who experienced immunity loss,
is given by the number g(zmin)r(t, zmin) of immune hosts who reached the
minimal level of immunity after recovery from natural infection. Similarly,
ΛV is the number g(zmin)v(t, zmin) of vaccinated hosts who reached the
minimal level of immunity. Hence we have
S˙2(t) = − βS2(t)I(t)
N(t)︸ ︷︷ ︸
infection
− dS2(t)︸ ︷︷ ︸
death
+ g(zmin)r(t, zmin)︸ ︷︷ ︸
ΛR
+ g(zmin)v(t, zmin)︸ ︷︷ ︸
ΛV
.
(8)
In the following we refer to the complete system (2) – (8) as to model
(V1).
4. Connection to Other Mathematical Models
4.1. Connection to ODE models
As it was shown by Barbarossa and Ro¨st6 for a simpler problem, model
(V1) can be reduced to a system of ODEs analogous to those proposed
by several authors31,11,3,22,17,30. The connection between model (V1) and
the ODE system is given by the method of lines, a technique in which all
but one dimensions are discretized34. In our case, we shall discretize the
immunity level (z) and obtain a system of ODEs in the time variable.
Let us define a sequence {zj}j∈N, with hj := zj+1−zj > 0, for all j ∈ N. To
keep the demonstration as simple as possible, we choose a grid with only
a few points, z1 := zmin < zW := zvax < zF < zmax and for simplicity
(or possibly after a rescaling) assume that hj = 1 for all j. We define the
following subclasses of the immune/vaccinated population:
• RF (t) := r(t, zF ), immune hosts with high level of immunity at
time t. As their immunity level is quite high, these individuals do
not experience immune system boosting. Immunity level decays at
rate µ := g(zF ) > 0.
• RW (t) := r(t, zW ), immune hosts with intermediate level of immu-
nity at time t. These individuals can get immune system boosting
and move to RF . Immunity level decays at rate ν := g(zW ) > 0.
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• RC(t) := r(t, zmin), immune hosts with critically low level of immu-
nity at time t. With probability θ boosting moves RC individuals
to RW (respectively, with probability (1 − θ) to RF ). Immunity
level decays at rate σ := g(zmin) > 0. If they do not get im-
mune system boosting, these hosts move to the class S2 (become
susceptible again).
• VR(t) := v(t, zF ), vaccinated hosts who thanks to immune system
boosting gained a very high level of immunity at time t. These
individuals do not experience immune system boosting. Immunity
level decays at rate µ.
• V0(t) := v(t, zW ), vaccinated individuals at time t with maximal
vaccine-induced immunity. This class includes new vaccinees. If
their immune system gets boosted hosts move to VR. Immunity
level decays at rate ν.
• VC(t) := v(t, zmin), vaccinees with critically low level of immunity
at time t. With probability ξ boosting moves VC hosts to V0 and
with probability (1 − ξ) to VR. Immunity level decays at rate σ.
If they do not receive immune system boosting, VC hosts move to
S2.
To show how the PDE system can be reduced to a system of ODEs by
means of the method of lines, we consider a simple example. Let us neglect
immune system boosting for a moment. Then the PDE for r(t, z) in model
(V1) becomes
∂
∂t
r(t, z) =
∂
∂z
(
g(z)r(t, z)
)− dr(t, z), z ∈ [zmin, zmax], (9)
with boundary condition Rzmax(t) := r(t, zmax) = γI(t)/g(zmax). Using
forward approximation for the z-derivative in (9), we obtain, e.g., for RF (t)
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the following differential equation:
R˙F (t) =
∂
∂t
r(t, zF )
=
∂
∂z
(
g(zF )r(t, zF )
)− dr(t, zF )
≈ g(zmax)r(t, zmax)− g(zF )r(t, zF )
zmax − zF︸ ︷︷ ︸
=1
− dr(t, zF )
= g(zmax)Rzmax(t)− µRF (t)− dRF (t)
= γI(t)− (µ+ d)RF (t).
Analogously one can find equations for RW , RC , VR, V0 and VC . Alto-
gether we obtain a system of ordinary differential equations in which a
linear chain of ODEs replaces the PDEs for the immune and the vaccinated
class:
S˙(t) = (1− α)b(N(t)) − φS(t)− βS(t)I(t)
N(t)
− dS(t)
I˙(t) = β
I(t)
N(t)
(S(t) + S2(t)) − (γ + d+ dI)I(t)
R˙F (t) = γI(t)− µRF (t)− dRF (t)
R˙W (t) = µRF (t)− νRW (t)− dRW (t)
R˙C(t) = νRW (t)− σRC(t)− dRC(t)
V˙R(t) = −µVR(t)− dVR(t)
V˙0(t) = φS(t) + αb(N(t)) + µVR(t)− νV0(t)− dV0(t)
V˙C(t) = νV0(t)− σVC(t)− dVC(t)
S˙2(t) = −βS2(t)I(t)
N(t)
− dS2(t) + σ(RC(t) + VC(t)).
The method of lines can be applied to the full model (V1) as well6. To this
purpose it is necessary to discretize the boosting probability p(z, z˜) (this is
expressed by the parameters ξ and θ below). Incorporating the boosting
effect, the result is the following system of ODEs.
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S˙(t) = (1− α)b(N(t)) − φS(t)− βS(t)I(t)
N(t)
− dS(t)
I˙(t) = β
I(t)
N(t)
(S(t) + S2(t))− (γ + d+ dI)I(t)
R˙F (t) = γI(t)− µRF (t) − dRF (t) + β I(t)
N(t)
(RW (t) + (1 − θ)RC(t))
R˙W (t) = µRF (t)− νRW (t)− dRW (t) + β I(t)
N(t)
(θRC(t)−RW (t))
R˙C(t) = νRW (t)− σRC(t)− dRC(t)− β I(t)
N(t)
RC(t)
V˙R(t) = β
I(t)
N(t)
(V0(t) + (1− ξ)VC(t))− µVR(t)− dVR(t)
V˙0(t) = φS(t) + αb(N(t)) + µVR(t)− νV0(t)− dV0(t)
+ β
I(t)
N(t)
(ξVC(t)− V0(t))
V˙C(t) = νV0(t)− σVC(t)− dVC(t)− βVC(t)I(t)
N(t)
S˙2(t) = −βS2(t)I(t)
N(t)
− dS2(t) + σ(RC(t) + VC(t)).
The linear chain of ODEs provides a rough approximation of the PDEs in
model (V1). Indeed, with the method of lines we approximate the PDE dy-
namics considering only changes at the grid points (zmin, zW , zF ), whereas
the dynamics remains unchanged in each immunity interval [zj, zj+1]. We
consider as representative point of the interval the lowest boundary zj - for
this reason we do not have a differential equation for Rzmax(t) or Vzmax(t).
4.2. Connection to DDE models
Delay models with constant delay can be recovered from special cases of
model (V1). We show here how to obtain the classical SIRS model with
delay studied by Taylor and Carr36, or extensions thereof.
In the following we neglect boosting effects and vaccination. Further we
do not distinguish between originally susceptibles and host who have lost
immunity, hence w.r.t. model (V1) we identify the classes S and S2. From
our assumptions, the disease-induced immunity lasts for a fix time, τ > 0
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years, given by ∫ zmax
zmin
1
g(x)
dx = τ.
We can express the total immune population at time t as the number of
individuals who recovered in the time interval [t− τ, t],
R(t) = γ
∫ t
t−τ
I(y)e−d(t−y) dy = γ
∫ τ
0
I(t− x)e−dx dx.
Differentiation with respect to t yields
R˙(t) = γI(t)− γI(t− τ)e−dτ − dR(t). (10)
On the other side, we have the definition in terms of distribution of immune
individuals,
R(t) =
∫ zmax
zmin
r(t, z) dz.
Differentiate the last relation and compare with (10):
g(zmax)r(t, zmax) = γI(t), g(zmin)r(t, zmin) = γI(t− τ)e−dτ .
This means that individuals with maximal level of immunity are those who
recover from infection. If a host who recovers at time t1 survives up to time
t1+τ , he exits the R class and enter S. In turn, we find a delay term in the
equation for S too, and have a classical SIRS model with constant delay
S˙(t) = b(N(t))− βS(t)I(t)
N(t)
− dS(t) + γI(t− τ)e−dτ
I˙(t) = β
S(t)I(t)
N(t)
− (γ + d+ dI)I(t)
R˙(t) = γI(t)− γI(t− τ)e−dτ − dR(t),
which was studied by Taylor and Carr36.
Now we can include again vaccination and the class S2 as in the general
model (V1). We assume that vaccine-induced immunity lasts for a time
τv > 0,
τv :=
∫ zvax
zmin
1
g(x)
dx <
∫ zmax
zmin
1
g(x)
dx =: τ.
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With similar arguments as for the immune population, we obtain the rela-
tions
g(zvax)v(t, zvax) = αb(N(t)) + φS(t),
g(zmin)v(t, zmin) = (αb(N(t− τv)) + φS(t− τv)) e−dτv ,
and find a system with two constant delays
S˙(t) = (1− α)b(N(t)) − φS(t)− βS(t)I(t)
N(t)
− dS(t)
I˙(t) = β
I(t)
N(t)
(S(t) + S2(t))− (γ + d+ dI)I(t)
R˙(t) = γI(t)− γI(t− τ)e−dτ − dR(t)
V˙ (t) = αb(N(t)) + φS(t)− (αb(N(t− τv)) + φS(t− τv)) e−dτv − dV (t)
S˙2(t) = −βS2(t)I(t)
N(t)
− dS2(t) + γI(t− τ)e−dτ
+ (αb(N(t− τv)) + φS(t− τv)) e−dτv .
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